sodium polydeoxyribonucleotide Cream 0.8mg / g

It is a biopharmaceutical firm that realizes a new treatment paradigm for regenerative medicine which may be applied in various corners of life central to PDRN and PN, which are new concepts of tissue regenerating active substances. The company was founded in the 1990s and it has expanded its business area starting from consulting for drug licensing, import, and sales of innovative drugs.